Munafa Stock Market Course + Intraday & FNO calls 
SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC
Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in PharmaceuticalsAnnouncements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC
Kirti Ganorkar: Why the veteran insider is the right dose for Sun Pharma
Kirti Ganorkar, a long-time Sun Pharma veteran, will take over as Managing Director from September 1, succeeding founder Dilip Shanghvi, who remains Executive Chairman. This transition marks the culmination of Sun Pharma's succession plan, as Ganorkar step
Announcement as on 14 June 2025
Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials
Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to discontinue development of the drug. Separately, a surpri
Announcement as on 04 June 2025
New launches to drive Sun Pharma’s future growth; PAT may take a hit by tax surge
Sun Pharma anticipates revenue growth for fiscal year 26, building on an 8% increase in fiscal year 25. However, increased spending on marketing specialty products may impact profitability. Net profit declined in the March quarter due to higher taxes. The
Announcement as on 02 June 2025
Sun Pharma lines up 0 mn to commercialise niche products this fiscal
Sun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, focusing on its specialty business. The company will launch Unloxcyt and Leqselvi, while seeking a partner for MM-II development. Sun Ph
Announcement as on 01 June 2025
Sun Pharma Q4 Results: Cons PAT falls 19% YoY to Rs 2,154 crore; Rs 5.5/share dividend announced
Sun Pharma reported a 19% YoY drop in Q4FY25 net profit to Rs 2,154 crore, while revenue rose 8% to Rs 12,959 crore. Final dividend set at Rs 5.50/share.
Announcement as on 22 May 2025
Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |
SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals
Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 16 Tue Jun 2026 | 238.41 | 230.25 to 240.80 | 4.1% | 0.79 times |
| 15 Mon Jun 2026 | 229.03 | 220.26 to 233.90 | 2.36% | 0.99 times |
| 12 Fri Jun 2026 | 223.76 | 205.81 to 224.52 | 9.63% | 1.99 times |
| 11 Thu Jun 2026 | 204.11 | 202.19 to 213.00 | -0.88% | 0.56 times |
| 10 Wed Jun 2026 | 205.92 | 204.20 to 214.80 | -1.56% | 0.51 times |
| 09 Tue Jun 2026 | 209.19 | 204.00 to 209.93 | 2.75% | 0.81 times |
| 08 Mon Jun 2026 | 203.60 | 201.10 to 214.17 | -4.33% | 0.54 times |
| 05 Fri Jun 2026 | 212.82 | 210.90 to 222.59 | -0.07% | 0.89 times |
| 04 Thu Jun 2026 | 212.97 | 205.01 to 215.79 | 2.14% | 0.8 times |
| 03 Wed Jun 2026 | 208.50 | 196.50 to 210.59 | 2.09% | 1.19 times |
| 02 Tue Jun 2026 | 204.24 | 194.10 to 207.38 | 4.01% | 1.72 times |
| 01 Mon Jun 2026 | 196.37 | 195.45 to 215.37 | -7.42% | 1.55 times |
Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
